Protalix Biotherapeutics shares rise 5.81% intraday after CEO to present at H.C. Wainwright conference.

Protalix Biotherapeutics, Inc. rose 5.81% in intraday trading, with the company announcing that its President and Chief Executive Officer, Dror Bashan, will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025. The presentation is expected to provide insights into the company's developments and future prospects, which may have contributed to the positive market sentiment.